Epix To Advance COPD, Alzheimer’s Drugs
This article was originally published in The Pink Sheet Daily
Firm moving ahead after failed depression trial.
You may also be interested in...
Firm tries again with PRX-03140/donepezil combo.
Epix will file an NDA in mid-2008 following positive results from reevaluation of the vascular imaging agent.
Alzheimer’s candidate in development with GlaxoSmithKline advances.